A Systematic Review of Economic Evaluations of Pharmacogenetic Testing for Prevention of Adverse Drug Reactions

Background Pharmacogenetics offers the potential to improve health outcomes by identifying individuals who are at greater risk of harm from certain medicines. Routine adoption of pharmacogenetic tests requires evidence of their cost effectiveness. Objective The present review aims to systematically...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	PharmacoEconomics Ročník 34; číslo 8; s. 771 - 793
Hlavní autori:	Plumpton, Catrin O., Roberts, Daniel, Pirmohamed, Munir, Hughes, Dyfrig A.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Cham Springer International Publishing 01.08.2016 Springer Springer Nature B.V
Predmet:	Adverse and side effects Cost-Benefit Analysis Drug-Related Side Effects and Adverse Reactions - economics Drug-Related Side Effects and Adverse Reactions - epidemiology Drug-Related Side Effects and Adverse Reactions - prevention & control Drugs Economic aspects Evaluation Genotype Health Administration Health Economics Humans Incidence Medicine Medicine & Public Health Methods Pharmacoeconomics and Health Outcomes Pharmacogenetics Pharmacogenetics - economics Pharmacogenetics - methods Pharmacogenomic Testing - economics Pharmacogenomic Testing - methods Public Health Quality of Life Research Side effects Systematic Review United Kingdom Prasugrel Clopidogrel Economic Evaluation Carbamazepine Abacavir
ISSN:	1170-7690, 1179-2027
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!